About
Categories
Products
Newsfeed
How to Buy
Newsfeed
How to Buy
    1. Products
    2. Dairy Ingredients
    3. Dairy Ingredients by Type
  3. Specialty
  4. Probiotics

Probiotics

Live micro-organisms to support health

Globally, 1 in 2 consumers have purchased probiotic products in the past year. 

Digestive and immunity benefits are among the top reasons for probiotic use (FMCG Gurus, 2018)

 

NZMP’s unique probiotic strains LactoB HN001TM and BifidoB HN019TM, address these key health concerns, enabling customers to appeal to a broad range of consumers through digestive health and immunity positioning. Additionally, our probiotics are Non-GMO Project Verified, to appeal to the 46% of consumers who actively avoid GMOs. 

 

Note: the scientific name for LactoB HN001 is Lacticaseibacillus rhamnosus HN001*; BifidoB HN019 is Bifidobacterium animalis lactis HN019.

Please Drag & Drop Background Image from Toggle Side Panel > Assets

For Paediatric Nutrition

For Adult Lifestyles

Nutiani HN001™

Nutiani HN001™

Probiotics LactoB HN001™ is an extensively researched probiotic that supports a healthy immune system and digestive health by improving gut integrity and barrier function.
Nutiani HN019™

Nutiani HN019™

Probiotic BifidoB HN019™ is an  extensively- researched probiotic that helps to reduce gut discomfort, and constipation, whilst reducing risk of certain types of infection.

Interested in one of these ingredients?

Get in touch

Whitepaper: Small but Mighty | Digestive Wellness

Whitepaper: A Good Fight | Probiotics & Immunity

Whitepaper: A Turning Point | Probiotics & Mental Wellbeing

The development of probiotics

Over 20 years ago our Microbial Fermentation Unit (MFU) began screening 2000+ bacterial strains to identify potential probiotics.

 

Through vigorous testing and extensive research, we have selected the best strains for commercialisation.

 

This extensive process led to the discovery of LactoB HN001TM isolated from a New Zealand cheddar cheese culture, and BifidoB HN019TM from a yoghurt culture. Both strains have also been Non-GMO Project Verified.

The 'secret' to success

Our MFU represents cross-functional expertise in the highly specialised field of microbial cultures, including probiotics. Originally opened in 1927, the MFU is the only facility in New Zealand to manufacture commercial probiotic cultures via fermentation. Its world-class operations boast specialised facilities with ISO, FSSC, Halal and Kosher accreditations.  

 

As the founding section of Fonterra Research & Development Centre (FRDC), and now part of our global manufacturing network, MFU has strong ties to Massey University and other industry organisations.

 

MFU’s support network through FRDC provides customers with access to technical support to address needs across shelf-life stability modelling, NPD support or formulation and clinical research. 

Industry Involvement

In 2020, Fonterra renewed its membership of both the International Probiotics Association (IPA) and the International Scientific Association for Probiotics and Prebiotics (ISAPP).

 

Our IPA membership sees us join other key probiotic industry players. It reflects our ongoing commitment to upholding the highest manufacturing standards and promotion of the health benefits of probiotic strains supported by high-quality scientific evidence. Likewise, our ISAPP membership allows us to remain at the forefont of global scientific innovation in probiotic and prebiotic science.

Why NZMP Probiotics?

Our approach to probiotics

NZMP's probiotic strains tick all the boxes to give customers confidence about:

  • Safety: Our strains have US FDA GRAS status, and well-established history of use, with studies showing no adverse side effects. For consumers concerned about genetic modification, our strains also have Non-GMO Project Verification. 
  • Stability: Our strains can survive the harsh conditions of the human gastrointestinal tract. Our proprietary manufacture techniques deliver specs with high survival rates. This provides customers with shelf-life advantages and ensures our probiotics reach consumers in a viable state to deliver health benefits.
  • Effectiveness: We have scientific evidence across in vitro and in vivo studies (both animal and human research) which clinically document various health benefits. The quality of our studies is recognised in over 80 peer-reviewed publications. 

Receive the latest NZMP news, insights & updates direct to your inbox